Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock-Reference-Cited by-同舟云学术

Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock

Published:2018-04-30 Issue:5 Volume:38 Page:531-538
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Hammond Drayton A.¹^ORCID,Ficek Oktawia A.²^ORCID,Painter Jacob T.²,McCain Kelsey³,Cullen Julia⁴,Brotherton Amy L.⁵,Kakkera Krishna³,Chopra Divyan²,Meena Nikhil³⁶

Affiliation:

1. Rush University Medical Center; Chicago Illinois

2. University of Arkansas for Medical Sciences College of Pharmacy; Little Rock Arkansas

3. University of Arkansas for Medical Sciences Medical Center; Little Rock Arkansas

4. Mount Sinai Hospital; New York New York

5. Miriam Hospital; Providence Rhode Island

6. University of Arkansas for Medical Sciences College of Medicine; Little Rock Arkansas

Funder

American College of Clinical Pharmacy Research Institute

Publisher

Wiley

Subject

Pharmacology (medical)

Reference25 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Singer;JAMA,2016

2. Torio CM Moore BJ National inpatient hospital costs: the most expensive conditions by payer, 2013 http://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.pdf

3. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations;Fleischmann;Am J Respir Crit Care Med,2016

4. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016;Rhodes;Crit Care Med,2017

5. Vasopressin versus norepinephrine infusion in patients with septic shock;Russell;N Engl J Med,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-Analysis of the Timing of Vasopressor Therapy in Patients with Septic Shock: Assessing Clinical Outcomes and Implication;2024-04-29

2. A Systematic Review and Meta-Analysis of the Timing of Vasopressor Therapy in Patients with Septic Shock: Assessing Clinical Outcomes and Implication;F1000Research;2024-04-18

3. Clinical efficacy and safety of vasopressin and its analogues in patients with septic shock: a meta-analysis and trial sequential analysis;2024-02-28

4. Vasopressin in Sepsis and Other Shock States: State of the Art;Journal of Personalized Medicine;2023-10-29

5. Vasopressin Initiation as a Second-Line VasoPressor in Early Septic Shock (VISPSS);Journal of Intensive Care Medicine;2023-09-16